Jeffrey T. Walsh
2018
In 2018, Jeffrey T. Walsh earned a total compensation of $9.3M as Chief Strategy Officer at bluebird bio, a 93% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,900 |
|---|---|
| Option Awards | $6,269,843 |
| Salary | $450,000 |
| Stock Awards | $2,309,063 |
| Other | $12,250 |
| Total | $9,276,056 |
Walsh received $6.3M in option awards, accounting for 68% of the total pay in 2018.
Walsh also received $234.9K in non-equity incentive plan, $450K in salary, $2.3M in stock awards and $12.3K in other compensation.
Rankings
In 2018, Jeffrey T. Walsh's compensation ranked 789th out of 14,244 executives tracked by ExecPay. In other words, Walsh earned more than 94.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 789 out of 14,244 | 95th |
Division Manufacturing | 262 out of 5,762 | 96th |
Major group Chemicals And Allied Products | 76 out of 2,125 | 96th |
Industry group Drugs | 59 out of 1,814 | 97th |
Industry Biological Products, Except Diagnostic Substances | 17 out of 339 | 95th |
Source: SEC filing on April 23, 2019.
Walsh's colleagues
We found four more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2018.